Initiate the Phase 3 clinical trial of tesamorelin for NASH
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 30 Sep 2021
- Checked
- 27 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The Company intends to initiate the Phase 3 clinical trial by the end of the third quarter of calendar year 2021.”
What we found
Evidence strength A What the grades mean
Filings after the September 2021 deadline say the Phase 3 initiation was delayed and, in March 2022, paused; no initiation is reported.
-
A Theratechnologies Inc. 6-K filed 2021-10-13
“we continue to explore opportunities to best execute the Phase 3 clinical trial evaluating tesamorelin, including seeking a partnership for this program” ✓ confirmed on the page
-
A Theratechnologies Inc. 6-K filed 2022-02-24
“the initiation of the Phase 3 clinical trial for tesamorelin has been delayed pending assessment of our options to best execute this program” ✓ confirmed on the page
-
A Theratechnologies Inc. 6-K filed 2022-04-13
“we have decided, in March 2022, to pause any activities related to the initiation of the Phase 3 trial in NASH” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- Phase 3 tesamorelin NASH clinical trial initiation
- Language
- Aspirational (“aims”, “intends”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: Final timing dependent on protocol and trial design adjustments recommended by FDA and EMA
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Theratechnologies Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C512717-024486 · Corrections policy